Activity
From research to marketing of pharmaceuticals
In every step of the 6 stages of the process from research and development to manufacturing and marketing of pharmaceuticals, we exploit all our technology and intelligence.
Putting Our Overseas Networks to Work
The initial aim of our overseas business strategy is to fully exploit the core antibody business of Kyowa Hakko Kirin. This involves moving forward with the global standardization of our enhanced antibody activity technologies, the acquisition of new antibodies and antigens through alliances and other means, and the early acquisition of primary patent rights. In addition, we will establish a long-term profit base in the key business area of Asia by enhancing our product lineup and undertaking the strategic integration of business operations in China. We are also formulating strategies to create sales channels in Europe and America that will ensure our sales network reaches every corner of the world.
